International Programs

FDA Globalization

Globalization is a fact of 21st century economic life. It has resulted in United States markets being composed of a myriad of imported goods that our consumers want and need. Based on the volume of imported products from specific areas, problems that have been associated with products over the years, and value to be derived from leveraging the activities and resources of trusted foreign counterpart regulatory authorities, U.S. FDA have established a permanent in-country presence in China, India, Europe, Latin America, and Sub-Saharan Africa. 

FDA presence in China, Latin America, India, and Europe


« Return to International Programs

Page Last Updated: 02/19/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.